Skip Navigation

JNCI Journal of the National Cancer Institute 2000 92(4):345; doi:10.1093/jnci/92.4.345
© 2000 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Khan, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khan, M. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 92, No. 4, 345, February 16, 2000
© 2000 Oxford University Press

CORRESPONDENCE

Re: Antiangiogenic Activity of Prostate-Specific Antigen

Masood A. Khan

Correspondence to: Massod A. Khan, M.D., Royal Free Hospital School of Medicine, Department of Urology, Pond St., London NW3 2QG, U.K.

Although prostate-specific antigen (PSA) has been shown by Fortier et al. (1) to inhibit endothelial cell proliferation, migration, . . . [Full Text of this Article]

REFERENCES


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?